Loading
Arteris, Inc. Stock: price and insider trades · United States
Insider Decl.
785
Thresholds
n/a
Buy Volume
€16
1 ops. · all time
Sell Volume
€88M
501 ops. · all time
Who traded when
BuySaleK. Charles Janac57 sales
Paul L. Alpern42 sales
Laurent R. Moll36 sales
Hawkins Nicholas B.24 sales
Raza Saiyed Atiq19 sales
Bayview Legacy, LLC11 sales
+3 other insiders
Since the insiders bought
- -76.5%Entry US$23.57 · Close at T+365 US$5.54
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Arteris, Inc. Strong Buy (bullish), based on 7 analysts. Average price target: US$37.29.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,166 of 26,246 companies
33.0
score / 100
Value33
Quality34
FCF yld0.5%
Earn yld-3.4%
EV/EBITDA·
ROE-131%
Gross mgn90%
Net mgn-49%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$20.93
Analyst consensus
7 analystsStrong buy
US$25.00Target US$37.29(+78%)US$50.00
Income statement
RevenueUS$70.6M
Gross profitUS$63.7M90% margin
EBITDA-US$26.9M-38% margin
Net income-US$34.7M-46.7% margin
Valuation
PER (forward)168.4x
P/Book15.2x
Beta1.90
Balance sheet & cash
Market capUS$1B
Total debtUS$6M
Free Cash FlowUS$5.3M
Debt / Equity13%
Profitability & ownership
ROE-131.4%
ROA-14.2%
% insiders19.9%
% institutions65.7%
Last declaration on 6 October 2026
Declarations785 total
605 shares0Common StockSEC:0001668897-26-000004:0
6,003 shares@ US$24.23790.013% mcap7.9% of flowCommon StockSEC:0001888542-26-000013:0
11,452 shares@ US$24.27410.024% mcap1.1% of flowCommon StockSEC:0001068987-26-000021:0
887 shares@ US$24.64310.0019% mcap0.5% of flowCommon StockSEC:0001888601-26-000011:0
1,931 shares@ US$24.64310.0042% mcap1.1% of flowCommon StockSEC:0001888601-26-000011:1
1,889 shares@ US$24.64310.0041% mcap1.1% of flowCommon StockSEC:0001888601-26-000011:2
893 shares@ US$24.64310.0019% mcap0.5% of flowCommon StockSEC:0001888601-26-000011:3
12,219 shares@ US$24.2880.026% mcap6.9% of flowCommon StockSEC:0001888601-26-000011:4
633 shares0Common StockSEC:0001375414-26-000005:0
2,003 shares@ US$24.660.0042% mcap100.0% of flowCommonSEC144:0001950047-26-010056
32,713 shares@ US$24.660.069% mcap29.6% of flowCommonSEC144:0001950047-26-010038
11,452 shares@ US$24.660.024% mcap100.0% of flowCommonSEC144:0001950047-26-010041
2,775 shares@ US$24.64310.0058% mcap0.6% of flowCommon StockSEC:0001068987-26-000020:1
1,843 shares@ US$24.64310.0039% mcap0.4% of flowCommon StockSEC:0001068987-26-000020:2
1,966 shares@ US$24.64310.0041% mcap0.4% of flowCommon StockSEC:0001068987-26-000020:3
2,500 shares@ US$9.280.0020% mcap3.6% of flowCommon StockSEC:0001888542-26-000012:1
6,500 shares@ US$23.83590.013% mcap24.0% of flowCommon StockSEC:0001888542-26-000012:2
100,000 shares@ US$23.82390.20% mcap21.3% of flowCommon StockSEC:0001068987-26-000020:0
692 shares@ US$24.64310.0015% mcap2.7% of flowCommon StockSEC:0001888542-26-000012:3
765 shares@ US$24.64310.0016% mcap3.0% of flowCommon StockSEC:0001888542-26-000012:4
1,181 shares@ US$24.64310.0025% mcap4.6% of flowCommon StockSEC:0001888542-26-000012:5
1,010 shares@ US$24.64310.0021% mcap3.9% of flowCommon StockSEC:0001888542-26-000012:6
4,000 shares@ US$0.560.0002% mcap0.3% of flowCommon StockSEC:0001888542-26-000012:0
100,000 shares@ US$23.82390.20% mcap23.1% of flowCommon StockSEC:0001888862-26-000017:0
300,000 shares@ US$23.640.61% mcap75.0% of flowCommonSEC144:0001950047-26-009980
25 of 785 declarations
About Arteris, Inc.
Nearly all filings at Arteris, Inc. are sales: 510 of 754, worth EUR 98,033,680 with a median of EUR 31,359. Only one purchase appears in the data: EUR 16, filed by Wayne C. Cantwell on October 29, 2021. This US technology company, valued at USD 937.8 million, has 19.9% of its capital held by insiders. There are also 138 grants, 47 option exercises and 58 filings of another kind.
The largest sale is Nicholas B. Hawkins's (VP and Chief Financial Officer): EUR 4,751,358 on May 15, 2026. On July 1, 2026, Bayview Legacy, LLC (10% Owner) and K. Charles Janac (President and CEO) each filed EUR 2,461,402.
Read moreShow less
The filing is concentrated in a few executives: Paul L. Alpern (VP and General Counsel) with 165 filings, 112 of them sales, K. Charles Janac with 143 (119 sales), Nicholas B. Hawkins with 117 (98) and Laurent R. Moll (Chief Operating Officer) with 115 (97). The filings were published between October 29, 2021 and October 6, 2026, with yearly volume from 17 in 2021 to 222 in 2026. The last twelve months hold 245, 186 of them sales.
